These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor suppressor LHPP suppresses cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cell lines. Ma L; Sun H; Xu X; Chen Y; Zhang L; Li S; Tang L J Physiol Biochem; 2022 Nov; 78(4):807-817. PubMed ID: 35796893 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma. Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation and xenograft tumor growth. Bi CQ; Kang T; Qian YK; Kang M; Zeng XH; Li LC PLoS One; 2024; 19(5):e0299522. PubMed ID: 38696452 [TBL] [Abstract][Full Text] [Related]
5. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis. Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846 [TBL] [Abstract][Full Text] [Related]
6. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients. Meng K; Li Z; Cui X J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621 [TBL] [Abstract][Full Text] [Related]
7. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
8. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875 [TBL] [Abstract][Full Text] [Related]
9. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
10. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression. Tian Q; Xiao Y; Wu Y; Liu Y; Song Z; Gao W; Zhang J; Yang J; Zhang Y; Guo T; Dai F; Sun Z Int J Mol Med; 2016 Nov; 38(5):1587-1595. PubMed ID: 28026002 [TBL] [Abstract][Full Text] [Related]
12. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells. Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429 [TBL] [Abstract][Full Text] [Related]
14. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM. Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway. Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339 [TBL] [Abstract][Full Text] [Related]
16. The protein histidine phosphatase LHPP is a tumour suppressor. Hindupur SK; Colombi M; Fuhs SR; Matter MS; Guri Y; Adam K; Cornu M; Piscuoglio S; Ng CKY; Betz C; Liko D; Quagliata L; Moes S; Jenoe P; Terracciano LM; Heim MH; Hunter T; Hall MN Nature; 2018 Mar; 555(7698):678-682. PubMed ID: 29562234 [TBL] [Abstract][Full Text] [Related]
17. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway. Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107 [TBL] [Abstract][Full Text] [Related]
18. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma. Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922 [TBL] [Abstract][Full Text] [Related]
19. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo. Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580 [TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]